Zu H X, Schut H A
Department of Pathology, Medical College of Ohio, Toledo 43699.
Carcinogenesis. 1991 Nov;12(11):2163-8. doi: 10.1093/carcin/12.11.2163.
The potent food mutagen 2-amino-3-methylimidazo[4,5-f]-quinoline (IQ) is carcinogenic in the CDF1 mouse, affecting the liver, lungs and forestomach. Females are approximately twice as sensitive as males to liver tumor induction. Using 32P-postlabeling assays, the dose-response of IQ-DNA adduct formation was determined in various organs of male and female CDF1 mice after single p.o. doses of IQ. To determine the possible correlation between IQ-DNA adduct formation, persistence and tumorigenicity in target organs, young adult male and female CDF1 mice were treated with a single p.o. dose (50 mg/kg) of IQ, and IQ-DNA adducts were isolated and quantitated in liver, lungs, forestomach, small intestine and large intestine over a 24 day period. In the range of 5-50 mg IQ/kg, IQ-DNA adduct formation was related to dose in all organs examined (liver, lungs, stomach, small intestine, large intestine). Total adduct formation (expressed as relative adduct labeling, RAL) 24 h after administration was highest in the liver (6.4-6.9 x 10(-7)) with lower levels, in decreasing order, in the large intestine, small intestine (non-target organs), forestomach and lungs (target organs). In all cases the major adduct, comprising 68-79% of the total, co-chromatographed with standard N-(deoxyguanosin-8-yl)-IQ. Up to three additional IQ-specific adducts could be detected. Except in the liver, adduct levels 24 h after administration of IQ were 2- to 3-fold higher in females than in males. There was no preferential retention of any one of the four adducts 1-24 days after administration of IQ. Beyond day 4 after administration, total adducts in the liver of females were approximately 2-fold higher than those in males, and the rate of removal from female lung was approximately 2-fold faster than that from male lung during the 1-24 day time period. Both these findings correspond to the known sex differences in IQ-induced tumor incidences in these organs. The higher adduct levels in non-target organs (intestines) as compared to target organs (lungs and stomach), combined with the absence of differential persistence of any individual adduct indicates that, in addition to adduct formation and persistence, other factors contribute to the target organ specificity of IQ in CDF1 mice.
强效食品诱变剂2-氨基-3-甲基咪唑[4,5-f]喹啉(IQ)对CDF1小鼠具有致癌性,会影响肝脏、肺和前胃。雌性对肝脏肿瘤诱导的敏感性约为雄性的两倍。使用32P后标记分析法,测定了雄性和雌性CDF1小鼠单次口服IQ后,各器官中IQ-DNA加合物形成的剂量反应。为了确定IQ-DNA加合物形成、持久性与靶器官致瘤性之间的可能相关性,对年轻成年雄性和雌性CDF1小鼠单次口服剂量为50 mg/kg的IQ,并在24天内分离并定量肝脏、肺、前胃、小肠和大肠中的IQ-DNA加合物。在5-50 mg IQ/kg范围内,IQ-DNA加合物的形成与所有检测器官(肝脏、肺、胃、小肠、大肠)中的剂量相关。给药后24小时,肝脏中总加合物形成(以相对加合物标记,RAL表示)最高(6.4-6.9×10-7),大肠、小肠(非靶器官)、前胃和肺(靶器官)中的水平较低,且依次递减。在所有情况下,主要加合物占总量的68-79%,与标准N-(脱氧鸟苷-8-基)-IQ共色谱。最多可检测到另外三种IQ特异性加合物。除肝脏外,IQ给药后24小时雌性加合物水平比雄性高2至3倍。IQ给药后1-24天,四种加合物中没有任何一种有优先保留现象。给药后第4天之后,雌性肝脏中的总加合物比雄性高约2倍,在第1-24天期间,雌性肺中加合物的清除率比雄性肺快约2倍。这两个发现都与这些器官中IQ诱导肿瘤发生率的已知性别差异相符。与靶器官(肺和胃)相比,非靶器官(肠道)中的加合物水平更高,且任何单个加合物均无差异持久性,这表明除了加合物形成和持久性外,其他因素也导致了IQ在CDF1小鼠中的靶器官特异性。